Polypilot product mascot

Introducing PolyPilot:

Our AI-Powered Mentorship Program

Learn More
Go to Polygence Scholars page
Aalya Arora's cover illustration
Polygence Scholar2024
Aalya Arora's profile

Aalya Arora

Class of 2027Dublin, California


Hello! My name is Aalya Arora. A bit about me is that I am an equestrian horse rider, martial artist, avid debater, and aspiring neuroscientist. My Polygence project explores potential synergies between nanotechnology and stem cell therapies as a target for Alzheimers disease. After my project is complete, I would like to share my research, gain experience with the neurodivergent, compete in science fairs, create a neuroscience-oriented mental wellness platform for youth, and publish a book about how divergency is bred through today's apotheosized practices and how we can enter an era of scientific mental wellness.


  • "Exploring Synergistic Potentials in Stem Cell Therapy and Nanotechnology to Advance Alzheimer's Disease Treatment" with mentor Nella (Working project)

Project Portfolio

Exploring Synergistic Potentials in Stem Cell Therapy and Nanotechnology to Advance Alzheimer's Disease Treatment

Started May 9, 2023

Abstract or project description

Alzheimer's disease (AD) renders an unprecedented threat to global healthcare systems due to its highly progressive pathology and the lack of effective therapeutic treatments. With the increasing aging population, there is a pressing need for innovative approaches that address the pathophysiology of AD and promise some degree of therapeutic intervention. In recent years, we have come to know more about combining stem cell therapies and the utilization of nanotechnology, and their synergistic potentials present a promising strategy to combat this severe neurodegenerative disorder.

The review highlights the critical role of stem cells in regenerating damaged neural tissues, promoting neurogenesis, and modulating inflammatory responses. It also emphasizes the immense potential of nanotechnology in ensuring precise delivery of therapeutic agents, enhancing drug bioavailability, and optioning real-time monitoring of disease progression.

Drawing upon the available literature, we analyze the synergy between stem cell therapy and nanotechnology, elucidating the concept of how integrating these cutting-edge approaches can potentially optimize treatment outcomes for AD; as well as providing a data-driven means of prevention that is genome sequencing and targeting specific malignant genes. Additionally, we address the challenges and limitations that must be overcome to translate these promising findings into safe and effective clinical applications.

In conclusion, this review sheds light on the significant progress made in harnessing the power of stem cell therapy and nanotechnology to combat Alzheimer's disease and detection through genome sequencing. By providing a comprehensive overview of the current landscape and highlighting the potential synergies between these fields, we aim to inspire further research and development toward the ultimate goal of developing transformative therapies for AD patients in the near future.